[In vitro fertilization (IVF): why doing it in stimulated cycles?].

Assisted reproductive technology is a difficult course for the couples. Our purpose is to be effective without damaging the patient and the child to be born. The cumulative rates of success are strictly dependent on the number of oocytes and on the obtained top quality embryos and thus on the realization of an effective stimulation.

[How to improve IVF results from a clinical point of view?].

This study reports the last data of the literature on the possibilities of optimizing chances of pregnancy during in vitro fertilization attempts, our research concerning only the clinical point of view while excluding biologic possibilities. The selection of the patients, the management of controlled ovarian hyperstimulation protocols, the optimalisation of the transfer and the luteal phase support will be cross-reviewed.

[Analysis of the cancellations and temporary suspensions: the FIVNAT data].

This article reports the results of the FIVNAT database concerning the cancellation of cycles in IVF programs. 8,980 cycles have been cancelled (11,5%), mostly because of a poor ovarian response to stimulation (66%). The chances of success of a second cycle of IVF following a cycle cancelled for poor ovarian response halved by 2 (compared with patients cancelled for HSO or for personal reasons).

[Fort Lauderdale congress report: advances in infertility treatment - Florida, 24-26 January 2002].

The goal of the treatment of infertility is to apply therapeutic techniques to patients in a safe manner and at the same time increase the chances for conceiving and delivering healthy babies: basic and clinical research is more and more finalized directed to these goals. The conference "Advances in Infertility Treatment" held in Fort Lauderdale, Florida on January 24-26, 2002 covered many clinical and research aspects of this important therapeutic area. Important discussed issues included the impact of age, lifestyle, and the genetic set-up of patients in the pathogenesis and development of infertility-causing disorders such as male reproductive dysfunction, polycystic ovary syndrome, and ovarian failure.